We pioneer breakthroughs in healthcare. For everyone. Everywhere.
Siemens Healthineers is a leading medical technology company with over 125 years of experience. Our product and service portfolio which is continuously developing from in-vitro and in-vivo diagnostics, is crucial for clinical decision-making and treatment pathways. With AI-supported applications and digital offerings this plays an increasingly important role in the next generation of medical innovations and means we are well positioned to take on the biggest challenges in healthcare.
Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care. Further information is available at www.siemens-healthineers.co.uk/poc
Our Point-of-Care Testing is designed to provide immediate, convenient, and easy-to-use diagnostic testing.
From the emergency department to primary care, clinical management decisions can be made immediately and result in improved patient safety, clinical outcomes, and overall patient satisfaction.
Should you wish to discuss any of our solutions please email: poc.team@siemens-healthineers.com and a member of our team will come back to you.
Siemens Healthineers offers a wide variety of Point of Care products and connectivity solutions. To view in more detail, please click the button below:
Every minute and every drop of blood count when caring for critically ill newborn
Accelerate treatment decision and minimise sampling for effective neonatal care.
Modernised Urinalysis Testing from Siemens Healthineers Expands Access, Makes Earlier Detection of Kidney Disease Possible
- Millions remain undiagnosed with kidney disease until advanced stages.
- Urinalysis supports earlier intervention and can help reduce costly treatments.
- The Atellica LumIQ Analyser minimises testing variability, supporting fast clinical decisions.
Siemens Healthineers is expanding access to modern urinalysis testing with the Atellica LumIQ Analyser, a portable and scalable point-of-care instrument designed for use on the frontlines of patient care.
The system, manufactured in Sudbury, United Kingdom, helps clinicians detect and monitor conditions such as kidney disease, urinary tract infections, pregnancy and diabetes, while enabling testing closer to the patient and providing earlier clinical insights than traditional laboratory based methods.
Latest innovation in diabetes care from Siemens Healthineers optimises diabetes management and enables early diagnosis
With diabetes cases on the rise globally1, early detection and management are critical to prevent health complications that occur when chronic conditions are left unmanaged.
The compact Atellica DCA Analyser delivers lab equivalent HbA1c and ACR results in minutes and provides flexibility both in its design and its workflow capabilities.
On demand testing minimises barriers to care by ensuring patients receive timely medical guidance without the need for additional appointments.
Siemens Healthineers has introduced its latest diabetes care innovation, the next-generation point-of-care Atellica DCA Analyser. Designed to optimise diabetes management and enable early diagnosis, the analyser empowers clinicians to conduct HbA1c and ACR testing at the point of care, delivering results within minutes. With diabetes cases on the rise, early detection and management are critical, yet nearly half of people with diabetes are undiagnosed.1 The Atellica DCA Analyser addresses key challenges such as large patient volumes and limited space, ensuring patients receive timely medical guidance and helping to remove the need for additional appointments.
Used for diagnosing and monitoring diabetes, the compact Atellica DCA Analyser produces HbA1c and ACR results in minutes and provides flexibility both in its design and workflow capabilities. Possessing a small footprint while maintaining the accuracy of central laboratory methods, the Atellica DCA Analyser is suitable for any testing environment. Clinicians can deliver care with confidence as proprietary Auto-Checks Technology runs internal checks and system calibrations throughout the analysis process to safeguard against sample loss and erroneous results. The analyser can also seamlessly transmit data via Wi-Fi or Ethernet to the provider’s LIS/HIS/EMR.
“Diabetes cases are rising, with estimates suggesting more than 780 million cases by 2045. By diagnosing early, we can help to prevent the health complications that occur when chronic conditions are left unmanaged," states Tobias Livingstone, Point of Care Business Lead at Siemens Healthineers Great Britain & Ireland. “The Atellica DCA Analyser enables HbA1c testing in a single interaction, supporting optimal diabetes management. This also minimises the barriers to care that patients may otherwise face if they needed to return to for further medical guidance after traditional testing."
More information on the Atellica DCA Analyser can be found here.
1 IDF diabetes atlas. 10th edition. Available from: http://www.diabetesatlas.org/
